Intervention

3'mRNA sequencing

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 1 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials1

Recruiting1

Common conditions13

Lead sponsors shown1

Clinical trials

1 shown

AYLo - AutoimmunitY and Loss of yNCT06696027 · 2024-11-15

RECRUITING

Common conditions

ANCA Associated Vasculitis (AAV)1 Asthma Bronchiale1 Connective Tissue Disease1 COPD1 Giant Cell Arteritis (GCA)1 Idiopathic Inflammatory Myopathies1 IgG4-Related Diseases1 Interstitial Lung Disease (ILD)1 Interstitial Lung Disease Due to Systemic Disease (Disorder)1 Polymyalgia Rheumatica (PMR)1 Psoriatic Arthritis (PsA)1 Rheumatoid Arthritis (RA)1 Sarcoidosis1

Leading sponsors

University of Bonn 1

Trial status mix

RECRUITING1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.